The ability of men to assess their suitability to take a phosphodiesterase type 5 inhibitor: An assessment of the comprehension of patient information materials

Journal of Sexual Medicine

Volumn 7, Issue 6, 2010, Pages 2217-2225

  Symonds, Tara ^a   Dean, John ^b   Coyne, Karin S ^c   Margolis, Mary Kay ^c   Hackett, Geoff ^d   Edwards, David ^e   Marfatia, Aditya ^f   Schnetzler, Gabriel ^f  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Court Gate House ^*  (United Kingdom)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d Holly Cottage   (United Kingdom)

^e White House Surgery   (United Kingdom)

^f PFIZER INC   (United States)

Author keywords

Erectile dysfunction; PDE5i use; Questionnaire; Sildenafil

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADULT; ARTICLE; COMPREHENSION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; ERECTILE DYSFUNCTION; HEALTH CARE PERSONNEL; HUMAN; INTERNET; INTERVIEW; MALE; MEDICAL INFORMATION; PATIENT EDUCATION; PRIORITY JOURNAL; PUBLICATION; SELF EVALUATION; TELECOMMUNICATION; UNITED KINGDOM;

EID: 77953926491     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01767.x     Document Type: Article

References (19)

1. Rosen RC, Shabsigh R, Kuritzky L, Wang WC, Sides GD. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: A retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Curr Med Res Opin 2005, 21:1701-9.
2. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006, 166:207-12.
3. Matic H, McCabe MP. The impact of the use of PDE5 inhibitors for erectile dysfunction on the lives of Australian men. Int J Impot Res 2007, 19:418-23.
4. Chevret M, Jaudinot E, Sullivan K, Marrel A, De Gendre AS. Impact of erectile dysfunction (ED) on sexual life of female partners: Assessment with the Index of Sexual Life (ISL) questionnaire. J Sex Marital Ther 2004, 30:157-72.
5. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004, 1:6-23.
6. Althof SE, O'Leary MP, Cappelleri JC, Crowley AR, Tseng LJ, Collins S. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. J Urol 2006, 176:2132-7.
7. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003, 15:63-71.
8. De Berardis G, Pellegrini F, Franciosi M, Pamparana F, Morelli P, Tognoni G, Nicolucci A. Management of erectile dysfunction in general practice. J Sex Med 2009, 6:1127-34.
9. Banks I, Kirby M, Marfatia A, Symonds T, Carlsson M, Schnetzler G. Assessment, in a general population of men, of men's interaction with the healthcare system to obtain phosphodiesterase type 5 inhibitors. J Sex Med 2009, 6(2):143. suppl
10. Kahan SE, Seftel AD, Resnick MI. Sildenafil and the Internet. J Urol 2000, 163:919-23.
11. Vredenbregt MJ, Blok-Tip L, Hoogerbrugge R, Barends DM, de Kaste D. Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. J Pharm Biomed Anal 2006, 40:840-9.
12. Davis TC, Federman AD, Bass PF, Jackson RH, Middlebrooks M, Parker RM, Wolf MS. Improving patient understanding of prescription drug label instructions. J Gen Intern Med 2009, 24:57-62.
13. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001, 345:810-6.
14. Dean CA, Carlsson M, Marfatia A, Schnetzler G, Symonds T. Correlation between community pharmacist and physician recommendation for treatment with a PDE5i. J Sex Med 2009, 6(2):91. suppl
15. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005, 17:307-19.
16. Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther 2001, 23:1707-19.
17. Melin JM, Struble WE, Tipping RW, Reynolds JM, Vassil TC, Levy SJ, Petrohoy TM, Midgette P, Hemwall EL, Levine JG, Irvin JD. A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM). Am J Cardiol 2004, 94:1243-8.
18. Assessment report for Alli, International nonproprietary name: Orlistat. EMEA, European Medicines Agency; 2009
19. Feibus KB. 2006, Orlistat OTC, 60 mg capsules GlaxoSmithKline (GSK) Consumer Healthcare New Drug Application 21-887 Actual Use Study NM17285